Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jul 31:3:149.
doi: 10.4103/2277-9175.137831. eCollection 2014.

Long-term results of pleurodesis in malignant pleural effusions: Doxycycline vs Bleomycin

Rahmatollah Rafiei  1 , Behnam Yazdani  1 , Sayed Milad Ranjbar  1 , Zahra Torabi  1 , Sedigheh Asgary  2 , Somayeh Najafi  3 , Mahtab Keshvari  2
Affiliations

Long-term results of pleurodesis in malignant pleural effusions: Doxycycline vs Bleomycin

Rahmatollah Rafiei et al. Adv Biomed Res. .

Abstract

Background: The aim of this study was to compare the response of doxycycline and bleomycin in pleurodesis of malignant pleural effusions.

Materials and methods: The radiologic and clinical responses of doxycycline and bleomycin in pleurodesis of malignant pleural effusions were compared in this randomized clinical trial. Forty-two patients were randomized to receive either bleomycin 45 mg or doxycycline 600 mg as the sclerotherapy agent. Chest X-rays were taken before and after intervention, 10 days and 2 months later to compare the radiologic response. Dyspnea and other side effects, before and after intervention, 10 days and 2 months later were recorded and compared. Chi-square test was applied to analyze the data.

Results: The prevalence of dyspnea and its different severities, 10 days and 2 months after intervention were significantly different (P < 0.05) between the two groups. Analysis of pleural effusions revealed a significant difference (P < 0.05) between Doxycycline vs. Bleomycin 2 months after the intervention. Three months after pleurodesis, only one patient in bleomycin group needed pleural fluid drainage.

Conclusion: Pleural effusions did not change with use of doxycycline and bleomycin in short time but long-term results of doxycycline sclerotherapy was better than bleomycin sclerotherapy in malignant pleural effusions that was supported by this study. However, additional studies with larger sample size are necessary to confirm the results.

Keywords: Bleomycin; doxycycline; malignant pleural effusion; sclerotherapy.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

References

    1. Marchi E, Teixeira LR, Vargas FS. Management of malignancy-associated pleural effusion: Current and future treatment strategies. Am J Respir Med. 2003;2:261–73. - PubMed
    1. American Thoracic Society. Management of malignant pleural effusions. Am J Respir Crit Care Med. 2000;162:1987–2001. - PubMed
    1. Antunes G, Neville E. Management of malignant pleural effusions. Thorax. 2000;55:981–3. - PMC - PubMed
    1. Andrews CO, Gora ML. Pleural effusions: Pathophysiology and management. Ann Pharmacother. 1994;28:894–903. - PubMed
    1. Dimitriadis KA. Malignant pleural effusions. Arch Oncol. 2001;9:2.